RBC Capital reiterated coverage on DaVita with a new price target

10/29/21 9:25:06 AM ET

Misc Health and Biotechnology Services

Health Care

RBC Capital reiterated coverage of DaVita with a rating of Sector Perform and set a new price target of $111.00 from $113.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DVA

Date	Price Target	Rating	Analyst
3/6/2024	$133.00	Equal Weight	Barclays
8/7/2023	$100.00 → $142.00	Neutral → Buy	UBS
11/1/2022	$97.00 → $72.00	Buy → Hold	Deutsche Bank
10/31/2022	$117.00 → $74.00	Buy → Neutral	UBS
8/19/2022	$106.00 → $117.00	Buy	UBS
6/21/2022	$110.00 → $90.00	Underperform	BofA Securities
1/5/2022	$114.00 → $125.00	Hold	Truist Securities
10/29/2021	$113.00 → $111.00	Sector Perform	RBC Capital